PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>42</strong>/<strong>2000</strong><br />
15164 <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 19 Oct/oct <strong>2000</strong><br />
(71) ORTHO–MCNEIL PHARMACEUTI-<br />
CAL, INC. [US/US]; U.S. Route 202,<br />
Raritan, NJ 08869 (US).<br />
(72) CHEUNG, Wing, K.; Ortho–McNeil Pharmaceutical,<br />
Inc., US Route 202, Raritan,<br />
NJ 08869 (US). NATARAJAN, Jaya; Ortho–McNeil<br />
Pharmaceutical, Inc., US Route<br />
202, Raritan, NJ 08869 (US). SANDERS,<br />
Marilyn; Ortho–McNeil Pharmaceutical,<br />
Inc., US Route 202, Raritan, NJ 08869<br />
(US). VERCAMEN, Els; Ortho–McNeil<br />
Pharmaceutical, Inc., US Route 202, Raritan,<br />
NJ 08869 (US). SHARMA, Basant; Ortho–McNeil<br />
Pharmaceutical, Inc., US Route<br />
202, Raritan, NJ 08869 (US). BEGUN,<br />
Selima; Ortho–McNeil Pharmaceutical, Inc.,<br />
US Route 202, Raritan, NJ 08869 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG UZ VN<br />
YU ZA ZW; AP (GH GM KE LS MW SD<br />
SL SZ TZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE); OA (BF BJ CF CG CI CM GA GN<br />
GW ML MR NE SN TD TG).<br />
(51) 7 A61K 38/17, A61P 25/36<br />
(11) WO 00/61170 (13) A2<br />
(21) <strong>PCT</strong>/AT00/00090<br />
(22) 14 Apr/avr <strong>2000</strong> (14.04.<strong>2000</strong>)<br />
(25) de (26) de<br />
(30) A 667/99 14 Apr/avr 1999 AT<br />
(14.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) NOVEL MEDICAL USE OF 1–ACIDIC<br />
GLYCOPROTEIN (AAG) OR OROSO-<br />
MUCOID<br />
NOUVELLE UTILISATION<br />
MEDICALE DE GLYCOPRO-<br />
TEINE 1–ACIDE (AAG) OU<br />
D’OROSOMUCOIDE<br />
(71) HÄMOSAN ERZEUGUNG PHAR-<br />
MAZEUTISCHER GRUNDSTOFFE<br />
GESELLSCHAFT M.B.H. [AT/AT];<br />
Kahngasse 20, A–8045 Graz (AT).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) HIOTAKIS, Konstantin [AT/AT];<br />
Gritzenweg 8a, A–8020 Graz (AT). REI-<br />
CHL, Herwig, Ernst [AT/AT]; Neudorf 41,<br />
A–8262 Ilz (AT).<br />
(74) KÖHLER–PAVLIK, Johann et al. / etc.;<br />
Riemergasse 14, A–1010 Wien (AT).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 A61K 38/17, 39/395, A61P 43/00 // C12N<br />
15/12, C07K 14/705, 16/28, A01K 67/00,<br />
(A61K 38/17, 38:00) (A61K 38/17, 31:00)<br />
(11) WO 00/61171 (13) A2<br />
(21) <strong>PCT</strong>/US00/09719<br />
(22) 12 Apr/avr <strong>2000</strong> (12.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 09/290,825 13 Apr/avr 1999<br />
(13.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
US<br />
(54) NOVEL USES OF MAMMALIAN OX2<br />
PROTEIN AND RELATED REAGENTS<br />
NOUVELLES UTILISATIONS DE LA<br />
PROTEINE OX2 DE MAMMIFERE ET<br />
REACTIFS ASSOCIES<br />
(71) SCHERING CORPORATION [US/US];<br />
<strong>2000</strong> Galloping Hill Road, Kenilworth, NJ<br />
07033–053O (US).<br />
(72) HOEK, Robert, M.; 1943 Mount Vernon<br />
Court, #308, Mountain View, CA 94040<br />
(US). SEDGWICK, Jonathan, D.; 365<br />
<strong>No</strong>rth California Avenue, Palo Alto, CA<br />
94301 (US).<br />
(74) SCHRAM, David, B. et al. / etc.;<br />
Schering–Plough Corporation, Patent Department,<br />
K–6–1 1990, <strong>2000</strong> Galloping Hill<br />
Road, Kenilworth, NJ 07033–0530 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CZ DE DK DM DZ EE<br />
ES FI GB GD GE HR HU ID IL IN IS JP<br />
KG KR KZ LC LK LR LT LU LV MA MD<br />
MG MK MN MX NO NZ PL PT RO RU<br />
SE SG SI SK SL TJ TM TR TT TZ UA UZ<br />
VN YU ZA; AP (GH GM KE LS MW SD<br />
SL SZ TZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE); OA (BF BJ CF CG CI CM GA GN<br />
GW ML MR NE SN TD TG).<br />
(51) 7 A61K 38/21, A61P 35/00, G01N 33/574<br />
(11) WO 00/61172 (13) A1<br />
(21) <strong>PCT</strong>/EP00/04171<br />
(22) 10 Apr/avr <strong>2000</strong> (10.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 99/04480 9 Apr/avr 1999<br />
(09.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
FR<br />
(54) INTERFERON–BETA USE IN THE<br />
TREATMENT OF EWING’S FAMILY<br />
OF TUMORS<br />
UTILISATION D’INTERFERON–BETA<br />
DANS LE TRAITEMENT DE LA FA-<br />
MILLE DE TUMEURS D’EWING<br />
(71) INSTITUT NATIONAL DE LA SANTE<br />
ET DE LA RECHERCHE MEDICALE<br />
(INSERM) [FR/FR]; 101, rue de Tolbiac,<br />
F–75013 Paris (FR). INSTITUT CURIE<br />
[FR/FR]; 26, rue d’Ulm, F–75248 Paris<br />
Cedex 05 (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) SANCEAU, Josiane [FR/FR]; 2, allée<br />
des Feuillantines, F–94800 Villejuif (FR).<br />
WIETZERBIN, Jeanne [FR/FR]; 11, rue<br />
Jean Moulin, F–91160 Antony (FR).<br />
(74) JACOBSON, Claude; Cabinet Lavoix, 2,<br />
place d’Estienne d’Orves, F–75441 Paris<br />
Cedex 09 (FR).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DZ EE<br />
ES FI GB GD GE GH GM HR HU ID IL<br />
IN IS JP KE KG KP KR KZ LC LK LR LS<br />
LT LU LV MA MD MG MK MN MW MX<br />
NO NZ PL PT RO RU SD SE SG SI SK SL<br />
TJ TM TR TT UA UG US UZ VN YU ZA<br />
ZW; AP (GH GM KE LS MW SD SL SZ<br />
TZ UG ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE);<br />
OA (BF BJ CF CG CI CM GA GN GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/21, A61P 35/02<br />
(11) WO 00/61173 (13) A2<br />
(21) <strong>PCT</strong>/US00/09038<br />
(22) 5 Apr/avr <strong>2000</strong> (05.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 09/288,369 8 Apr/avr 1999<br />
(08.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) CML THERAPY<br />
THERAPIE ANTI–LMC<br />
US<br />
(71) SCHERING CORPORATION [US/US];<br />
<strong>2000</strong> Galloping Hill Road, Kenilworth, NJ<br />
07033–0530 (US).<br />
(72) RYBAK, Mary, Ellen; 5 Chesterfield Drive,<br />
Warren, NJ 07059 (US). ROSE, Esther,<br />
Helen; 755 Belvidere Avenue, Westfield, NJ<br />
07090 (US).<br />
(74) WYATT, Donald, W. et al. / etc.; Schering–Plough<br />
Corporation, Patent Dept.,<br />
K–6–1 1990, <strong>2000</strong> Galloping Hill Road,<br />
Kenilworth, NJ 07033–0530 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CZ DE DK DM DZ EE<br />
ES FI GB GD GE HR HU ID IL IN IS JP<br />
KG KR KZ LC LK LR LT LU LV MA MD<br />
MG MK MN MX NO NZ PL PT RO RU<br />
SE SG SI SK SL TJ TM TR TT TZ UA UZ<br />
VN YU ZA; AP (GH GM KE LS MW SD<br />
SL SZ TZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE); OA (BF BJ CF CG CI CM GA GN<br />
GW ML MR NE SN TD TG).<br />
(51) 7 A61K 38/21, A61P 35/00<br />
(11) WO 00/61174 (13) A2<br />
(21) <strong>PCT</strong>/US00/09127<br />
(22) 6 Apr/avr <strong>2000</strong> (06.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 09/288,359 8 Apr/avr 1999<br />
(08.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
US